Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Itolizumab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Equillium Announces Interim EQUATOR GVHD Enrollment Achieved
    Equillium Announces Interim EQUATOR GVHD Enrollment Achieved

    14 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240514537675/en

    BUSINESSWIRE
    14 May 2024
    Share Share
    Equillium Announces Positive Data from the Ph 1b EQUALISE study
    Equillium Announces Positive Data from the Ph 1b EQUALISE study

    01 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240401373328/en

    BUSINESSWIRE
    01 Apr 2024
    Share Share
    Equillium delivers new lupus data to Ono's doorstep
    Equillium delivers new lupus data to Ono's doorstep

    01 Apr 2024

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/equlliums-lupus-candidate-delivers-new-data-teeing-opt-decision-ono

    Max Bayer FIERCE BIOTECH
    01 Apr 2024
    Share Share
    Biocon starts clinical study to evaluate efficacy of Itolizumab
    Biocon starts clinical study to evaluate efficacy of Itolizumab

    15 Dec 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-starts-clinical-study-to-evaluate-efficacy-of-itolizumab/articleshow/96243936.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    15 Dec 2022
    Share Share
    Equillium and Ono Pharmaceutical Announce Agreement for Itolizumab
    Equillium and Ono Pharmaceutical Announce Agreement for Itolizumab

    06 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221206005379/en

    BUSINESSWIRE
    06 Dec 2022
    Share Share
    Equillium Reports Second Quarter 2022 Financial Results
    Equillium Reports Second Quarter 2022 Financial Results

    15 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220815005539/en

    BUSINESSWIRE
    15 Aug 2022
    Share Share